Chiral Ligands

L-AP3 is a selective antagonist of the PI-linked metabotropic glutamate response.

L-AP3 is a selective antagonist of the PI-linked metabotropic glutamate response.

L-p-Bromotetramisole oxalate is an inhibitor of non-specific alkaline phosphatase, comparable in activity to the vanadium compound Orthovanadate . L-p-Bromotetramisole oxalate shows no inhibition of specific phosphatase activity, and the D-

L-p-Bromotetramisole oxalate is an inhibitor of non-specific alkaline phosphatase, comparable in activity to the vanadium compound Orthovanadate . L-p-Bromotetramisole oxalate shows no inhibition of specific phosphatase activity, and the D-

L-p-Bromotetramisole oxalate is an inhibitor of non-specific alkaline phosphatase, comparable in activity to the vanadium compound Orthovanadate . L-p-Bromotetramisole oxalate shows no inhibition of specific phosphatase activity, and the D-

L-p-Bromotetramisole oxalate is an inhibitor of non-specific alkaline phosphatase, comparable in activity to the vanadium compound Orthovanadate . L-p-Bromotetramisole oxalate shows no inhibition of specific phosphatase activity, and the D-

L-p-Bromotetramisole oxalate is an inhibitor of non-specific alkaline phosphatase, comparable in activity to the vanadium compound Orthovanadate . L-p-Bromotetramisole oxalate shows no inhibition of specific phosphatase activity, and the D-

L-p-Bromotetramisole oxalate is an inhibitor of non-specific alkaline phosphatase, comparable in activity to the vanadium compound Orthovanadate . L-p-Bromotetramisole oxalate shows no inhibition of specific phosphatase activity, and the D-

L-p-Bromotetramisole oxalate is an inhibitor of non-specific alkaline phosphatase, comparable in activity to the vanadium compound Orthovanadate . L-p-Bromotetramisole oxalate shows no inhibition of specific phosphatase activity, and the D-

Lobeline hydrochloride is an alkaloid that acts on nicotinic cholinergic receptors but is less potent than nicotine. It is also a VMAT2 ligand and an antagonist of μ-opioid receptors.Solubility ≥37.5 mg/mL in EtOH with ultrasonic: ≥37.8 mg/mL in H2O

Lobeline hydrochloride is an alkaloid that acts on nicotinic cholinergic receptors but is less potent than nicotine. It is also a VMAT2 ligand and an antagonist of μ-opioid receptors.Solubility ≥37.5 mg/mL in EtOH with ultrasonic: ≥37.8 mg/mL in H2O

Lobeline hydrochloride is an alkaloid that acts on nicotinic cholinergic receptors but is less potent than nicotine. It is also a VMAT2 ligand and an antagonist of μ-opioid receptors.Solubility ≥37.5 mg/mL in EtOH with ultrasonic: ≥37.8 mg/mL in H2O